Comprehensive bioinformatics analysis of functional molecules in colorectal cancer

Tao Meng1, Zhangzhang Lan2, Xiaoling Zhao3

  • 1Department of Gastrointestinal Surgery, Xinjiang Medical University Tumor Hospital, Urumqi, China.

Abstract

Insights

This study identified key molecular players in colorectal cancer (CRC) development, revealing novel long non-coding RNAs, microRNAs, and messenger RNAs that could serve as diagnostic and therapeutic biomarkers for CRC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer-related death globally.
  • Aberrant molecular interactions are crucial in tumor development, impacting diagnosis, treatment, and prognosis.

Purpose of the Study:

  • To identify differentially expressed long non-coding RNAs (DElncRNAs), messenger RNAs (DEmRNAs), and microRNAs (DEmiRNAs) in colorectal cancer.
  • To construct a competing endogenous RNA (ceRNA) network and identify hub genes involved in CRC pathogenesis.

Main Methods:

  • Analysis of public datasets (GSE151021, GSE156720, GSE156719) to screen DElncRNAs, DEmRNAs, and DEmiRNAs.
  • Utilized bioinformatics tools (DAVID, GEPIA2, UALCAN, KM plotter, miRCancer, TargetScan, DIANA-LncBase v2) for gene enrichment, hub gene identification, survival analysis, and network construction.
  • Constructed a protein-protein interaction (PPI) and ceRNA network using Cytoscape.

Main Results:

  • Identified 23 upregulated and 10 downregulated DEGs in CRC tissues.
  • Highlighted NOP14, SHH, PMAIP1, BCL2, and ZEB2 as significant hub genes.
  • Constructed a lncRNA-miRNA-mRNA network involving 7 miRNAs, 79 lncRNAs, and 5 mRNAs, revealing dysregulation of specific lncRNAs (e.g., HCG16, CASC9) and miRNAs (e.g., hsa-miR-193a-5p) impacting CRC.

Conclusions:

  • Identified a series of DElncRNAs, DEmRNAs, and DEmiRNAs in colorectal cancer.
  • These molecules represent potential biomarkers for understanding CRC development.
  • The findings contribute to the diagnosis, treatment, and prognosis of colorectal cancer.